Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer. - Wikidata - awgldk - TriplyDB

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.

http://www.wikidata.org/entity/Q38151193

about

Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment Bevacizumab in ovarian cancer: A critical review of phase III studies Angiogenesis and antiangiogenic agents in cervical cancer.New ways to successfully target tumor vasculature in ovarian cancer.Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.An overview of tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer.Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.In Vitro Assays for Endothelial Cell Functions Required for Angiogenesis: Proliferation, Motility, Tubular Differentiation, and Matrix Proteolysis.

P2860

Q28075761-AE9501E9-0A63-41A8-AD45-C4F2EAEBBAE5 Q28076188-9FBE2263-2ECE-40EA-9709-15469DB1311D Q34655335-14308B50-77EF-489B-B607-8103A7B531F0 Q35928220-F5D484F3-C65A-4536-9076-BF78E21365DE Q38203882-C3D7D183-D297-4A7D-9935-775A920D5D4D Q38631272-8D0B26FC-B512-4E53-8F26-1C69B46A9067 Q38631373-7A55699C-87B6-4D7D-8127-0C0E23B43B17 Q39233197-47241E9A-5B49-4B32-BB6B-161DB9A16D68 Q53097666-38E40E2B-9F26-4A36-A69B-9F52C05E7816

P2860

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.

http://www.wikidata.org/entity/Q38151193

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.

@en

type

label

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.

@en

prefLabel

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.

@en

P1433

Q38151193-8BB99336-47D6-4ECB-AC20-95A4F61BDC7F

P1476

Q38151193-51CC3FFF-AEE5-4861-8006-BF1357925721

P2093

Q38151193-07D1BCB0-7C00-4042-B921-47D1EDDF8DAB

Q38151193-11B75DC7-BB8B-4859-AEC3-9E1A205571B9

Q38151193-C3D3E1A8-70EE-4A20-8F89-836613575FDD

Q38151193-D5F4D7D3-F94C-48BB-947E-EB1B64ABA252

Q38151193-E820264A-0826-4367-AD41-9E924E9E786F

P2860

Q38151193-01A734DA-5120-4500-BA21-39E7F592FF81

Q38151193-01B6CA8C-E76C-4D13-8C99-1C57693B83BD

Q38151193-02AE69CA-5373-41B3-8F0D-812C098610B4

Q38151193-0856530B-2D6D-4466-84BD-47015E6AF080

Q38151193-092E1ABC-DF94-494D-8919-7D6886061BF3

Q38151193-0C919C9E-542F-49C8-826C-E7037187A07A

Q38151193-10028BD3-3951-4605-B4CE-D7DF1E632E7D

Q38151193-1582859D-2993-41CB-A4AE-51791C241941

Q38151193-17EB1F97-D37A-4CF3-9D3D-6997734112E0

Q38151193-1CAC6637-17F5-45E4-AEA2-AA2DE0C2B235

P304

Q38151193-2650BFC2-F41C-4874-B7E6-C23F61AF8590

P31

Q38151193-A50F1C8B-400B-42DF-97CC-3E8D75BFBDA9

P356

Q38151193-770E4655-C243-4EC4-BBFE-554C25855955

P407

Q38151193-1ECBFCFC-B025-4C80-B388-9252B2164D3C

P433

Q38151193-CFAFE039-150D-457C-9739-E3E8CF06EC44

P478

Q38151193-54BBB48A-14FB-46D3-9B8A-9C74794EF3F8

P50

Q38151193-6248DF52-649C-436B-A35B-B0D5528D83ED

Q38151193-A6667037-C984-425E-853B-916A8D85B9E2

P577

Q38151193-7D8A9DD6-CE2C-402E-831D-CFE01DECAE6A

P5875

Q38151193-EE57DBA6-EDA6-4A8F-926B-694456D04550

P698

Q38151193-71ABCF9C-0DDE-40C2-9AA3-26D296DAFB18

P921

Q38151193-389B06EA-ECE5-49A6-852A-1543A4680450

Q38151193-6BE66217-C263-4EF3-B556-4D701208C0F9

P356

13543784.2013.839657

P1433

Expert Opinion on Investigational Drugs

P1476

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.

@en

P2093

Anselmo Papa

http://www.w3.org/2001/XMLSchema#string

Federica Tomao

http://www.w3.org/2001/XMLSchema#string

Federica Zoratto

http://www.w3.org/2001/XMLSchema#string

Luigi Rossi

http://www.w3.org/2001/XMLSchema#string

Silverio Tomao

http://www.w3.org/2001/XMLSchema#string

P2860

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy

Tumor angiogenesis: therapeutic implications

The biology of VEGF and its receptors

Cancer statistics, 2013

MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells

Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis

P304

37-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2013.839657

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Pierluigi Benedetti Panici

P577

2013-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257645591

http://www.w3.org/2001/XMLSchema#string

P698

24111925

http://www.w3.org/2001/XMLSchema#string

P921